Genetically risk-benefit-analysis

Cavalla, J. (ed.) (1981) Risk-Benefit Analysis in Drug Research, Boston MTP Press. Cavalli-Sforza, L. and Lederberg, J. (1956) Genetics, 41,367. 

Wu, F. (2004). Explaining public resistance to genetically modified com an analysis of the distribution of benefits and risks. Risk Anal. 24(3) 715-729. 

In ethical committees and public debates the emphasis is on the so-called extrinsic concerns the risks for human health, for animals and for the environment. Most methods of risk analysis look only at the consequences and the effects of genetic engineering within the framework of a utilitarian ethics (weighing costs and benefits). 

DNA analysis is used in the investigation of thalassemias and hemoglobinopathies to identify, in populations with a known high incidence of disease, those specific individuals at risk and who may benefit from genetic counseling. For example, DNA analysis has been used to ... 

---